A Phase II Trial of Valproic Acid in Patients With Advanced, Radioiodine-Resistant Thyroid Cancers of Follicular Cell Origin

Clinical Endocrinology - United Kingdom
doi 10.1111/cen.13154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers

Clinical Colorectal Cancer
OncologyGastroenterology
2014English

Phase I/Ii Trial of Imatinib and Bevacizumab in Patients With Advanced Melanoma and Other Advanced Cancers

Oncologist
Cancer ResearchMedicineOncology
2015English

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Phase I Study of Anti-Vegf Monoclonal Antibody Bevacizumab and Histone Deacetylase Inhibitor Valproic Acid in Patients With Advanced Cancers

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2014English

Binimetinib Plus Gemcitabine and Cisplatin Phase I/Ii Trial in Patients With Advanced Biliary Cancers

Clinical Cancer Research
Cancer ResearchOncology
2019English

The Epothilone B Analogue Ixabepilone in Patients With Advanced Hepatobiliary Cancers: A Trial of the University of Chicago Phase II Consortium

Investigational New Drugs
OncologyPharmacology
2009English

A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma

European Urology
Urology
2012English

A Phase II Trial of Tremelimumab (CP-675,206) in Patients With Advanced Refractory or Relapsed Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

A Phase IB Trial of 24-Hour Intravenous PX-12, a Thioredoxin-1 Inhibitor, in Patients With Advanced Gastrointestinal Cancers

Investigational New Drugs
OncologyPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy